Image pharmaphorum Editor R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics. Digital How can pharma teams optimise their HCP portals to strengthe... In recent years, pharma companies have invested heavily in their healthcare provider (HCP) portals, along with other digital solutions, to account for the reduction in face-to-face time bet R&D How Design of Experiments enriches life sciences’ findings Design of Experiments (DOE) is a methodology misunderstood by many, understood by some, and actively used by even fewer than that. Oncology Sponsored How can digital and AI optimise the delivery of patient supp... How can digital and AI optimise the delivery of patient support programs in cancer? Load more results
R&D A new dawn of the genomic age: five areas set to be transfor... 2022 was a banner year for genomics.
Digital How can pharma teams optimise their HCP portals to strengthe... In recent years, pharma companies have invested heavily in their healthcare provider (HCP) portals, along with other digital solutions, to account for the reduction in face-to-face time bet
R&D How Design of Experiments enriches life sciences’ findings Design of Experiments (DOE) is a methodology misunderstood by many, understood by some, and actively used by even fewer than that.
Oncology Sponsored How can digital and AI optimise the delivery of patient supp... How can digital and AI optimise the delivery of patient support programs in cancer?
News MSD adds rocket fuel to Winrevair's engine in PAH ZENITH trial of MSD's Winrevair in PAH could add further momentum to an already impressive launch
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
